Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity

Human Molecular Genetics
Malte ButzlaffAaron Voigt

Abstract

The gene mapt codes for the microtubule-associated protein Tau. The R406W amino acid substitution in Tau is associated with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) characterized by Tau-positive filamentous inclusions. These filamentous Tau inclusions are present in a group of neurodegenerative diseases known as tauopathies, including Alzheimer's disease (AD). To gain more insights into the pathomechanism of tauopathies, we performed an RNAi-based large-scale screen in Drosophila melanogaster to identify genetic modifiers of Tau[R406W]-induced toxicity. A collection of RNAi lines, putatively silencing more than 7000 genes, was screened for the ability to modify Tau[R406W]-induced toxicity in vivo. This collection covered more than 50% of all protein coding fly genes and more than 90% of all fly genes known to have a human ortholog. Hereby, we identified 62 genes that, when silenced by RNAi, modified Tau-induced toxicity specifically. Among these 62 modifiers were three subunits of the Dynein/Dynactin complex. Analysis on segmental nerves of fly larvae showed that pan neural Tau[R406W] expression and concomitant silencing of Dynein/Dynactin complex members synergistically caused strong patholog...Continue Reading

References

May 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M D WeingartenM W Kirschner
Oct 1, 1992·Molecular Biology of the Cell·D N DrechselM W Kirschner
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Nov 1, 1990·Journal of Neurogenetics·K E ZinsmaierE Buchner
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C M WischikA Klug
Dec 1, 1995·Molecular Biology of the Cell·B TrinczekE Mandelkow
Jun 18, 1998·Annals of Neurology·P PoorkajG D Schellenberg
Nov 12, 1998·The American Journal of Pathology·M G SpillantiniJ C van Swieten
Feb 27, 1999·Current Opinion in Cell Biology·S Karki, E L Holzbaur
Mar 10, 2000·Science·P Kazemi-Esfarjani, S Benzer
Aug 15, 2000·Journal of Structural Biology·R A Crowther, M Goedert
Nov 15, 2000·The Journal of Comparative Neurology·D W WilliamsD Shepherd
Jun 14, 2002·Neuron·Benjamin A EatonGraeme W Davis
Dec 10, 2002·Trends in Molecular Medicine·Esther M Ingram, Maria G Spillantini
May 15, 2003·Trends in Neurosciences·Fen-Biao Gao, Brigitte A Bogert
Jul 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Brian C KraemerGerard D Schellenberg
Dec 4, 2003·Neurobiology of Aging·E-M MandelkowE Mandelkow
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wyan-Ching Mimi LeeJ Troy Littleton
Apr 7, 2004·Cell·Marcel Tijsterman, Ronald H A Plasterk
May 14, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bin ZhangVirginia M-Y Lee
Sep 11, 2004·Human Molecular Genetics·Steven D BuckinghamDavid B Sattelle
Dec 24, 2004·Biochimica Et Biophysica Acta·Roland BrandtNeelam Shahani
Feb 26, 2005·Science·Gorazd B StokinLawrence S B Goldstein
Mar 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gang QinStephan J Sigrist
Sep 2, 2005·Nature Neuroscience·Tobias M RasseStephan J Sigrist
Sep 17, 2005·Nature Reviews. Molecular Cell Biology·Christopher A Ross, Michelle A Poirier
Feb 14, 2006·Neurobiology of Disease·Diane T W ChangIan J Reynolds
Apr 8, 2006·Human Molecular Genetics·Brian C KraemerGerard D Schellenberg
Oct 4, 2006·Neuron·J Lawrence Marsh, Leslie Michels Thompson
Jan 12, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robert H BalohJeffrey Milbrandt
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Johannes BischofKonrad Basler

❮ Previous
Next ❯

Citations

Apr 23, 2016·Journal of Alzheimer's Disease : JAD·Shan-Shan TangJin-Tai Yu
Jun 17, 2016·Journal of Neurochemistry·Liviu-Gabriel BodeaJürgen Götz
May 12, 2016·Ageing Research Reviews·Julia K GötzlAnja Capell
Sep 23, 2016·Frontiers in Cellular Neuroscience·Yao V ZhangTobias M Rasse
Aug 19, 2016·Molecular Biology of the Cell·Mugdha DeshpandeAvital A Rodal
Mar 11, 2017·Neuron·Fiona M MenziesDavid C Rubinsztein
Jan 22, 2019·Expert Opinion on Drug Discovery·Katerina PapanikolopoulouEfthimios Skoulakis
May 6, 2019·GeroScience·Alireza NazarianAlexander M Kulminski
Jun 5, 2020·Quarterly Reviews of Biophysics·Tessa SinnigeMichele Vendruscolo
Apr 24, 2018·Oxidative Medicine and Cellular Longevity·M PajaresM Cahova
Sep 27, 2019·Frontiers in Cell and Developmental Biology·Adina Maria PalhegyiSovan Sarkar
May 14, 2020·International Journal of Molecular Sciences·Hyungsun ParkSeongju Lee
Jul 12, 2018·Journal of Biomedical Science·Hui-Yun ChangAnn-Shyn Chiang
May 10, 2020·International Journal of Molecular Sciences·Hyeong Rok YunTae Gyu Choi
Jun 13, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Laura SchnöderYang Liu
Aug 31, 2021·The EMBO Journal·Daniel J KlionskyFederico Pietrocola
Jul 3, 2021·Molecular Neurobiology·Tarapati RanaSimona Bungau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: RNA Regulation

RNA regulation involves several mechanisms that are used by cells to decrease or increase the production of RNA. Disruption of RNA regulatory processes has been associated with Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA regulation and AD.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.